Trading Signals: SGEN Stock Price Prediction and Forecast (Fri. May. 30, 2003 - Wed. Dec. 13, 2023)(Seattle Genetics, Inc.)
| SGEN latest price $214.8150 (0.34%) ($214.8150 - $214.8150) on Mon. Oct. 16, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 0.79% (three month average) | RSI | 40 | Latest Price | $214.8150(0.34%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | SGEN advances 0.3% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support SGEN advance at 0% a week (0% probability) IGOV(32%) IWF(24%) VUG(22%) QQQ(20%) XLK(20%) | Factors Impacting SGEN price | SGEN will decline at least -0.395% in a week (0% probabilities). UNG(-31%) REMX(-24%) XME(-20%) XOP(-19%) GLD(-19%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.395% (StdDev 0.79%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $214.36(0.21%) | 10 Day Moving Average | $214.04(0.36%) | 20 Day Moving Average | $212.92(0.89%) | To recent high | -0.7% | To recent low | 12.1% | Market Cap | $37.349b | | | | Seattle Genetics, Inc. is a biotechnology company, which engages in the development and commercialization of antibody-based therapies for the treatment of cancer. Its products include Adcetris and Padcev. The firm is also advancing a pipeline of novel therapies for solid tumors and blood-related cancers. The company was founded by Clay B. Siegall and H. Perry Fell on July 15, 1997 and is headquartered in Bothell, WA. |